FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169916086> ?p ?o ?g. }

• W2169916086 abstract "Patients with mixed hyperlipidemia usually are in need of combination therapy to achieve low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG) target values for reduction of cardiovascular risk. This study investigated the efficacy and safety of adding a new hypolipidemic agent, coenzyme A (CoA) to stable statin therapy in patients with mixed hyperlipidemia. In this multi-center, 8-week, double-blind study, adults who had received ≥8 weeks of stable statin therapy and had hypertriglyceridemia (TG level at 2.3-6.5 mmol/L) were randomized to receive CoA 400 U/d or placebo plus stable dosage of statin. Efficacy was assessed by the changes in the levels and patterns of lipoproteins. Tolerability was assessed by the incidence and severity of adverse events (AEs). A total of 304 patients with mixed hyperlipidemia were randomized to receive CoA 400 U/d plus statin or placebo plus statin (n = 152, each group). After treatment for 8 weeks, the mean percent change in TG was significantly greater with CoA plus statin compared with placebo plus statin (-25.9% vs -4.9%, respectively; p = 0.0003). CoA plus statin was associated with significant reductions in TC (-9.1% vs -3.1%; p = 0.0033), LDL-C (-9.9% vs 0.1%; p = 0.003), and non- high-density lipoprotein cholesterol (-13.5% vs -5.7%; p = 0.0039). There was no significant difference in the frequency of AEs between groups. No serious AEs were considered treatment related. In these adult patients with persistent hypertriglyceridemia, CoA plus statin therapy improved TG and other lipoprotein parameters to a greater extent than statin alone and has no obviously adverse effect. Current Controlled Trials ClinicalTrials.gov ID NCT01928342 ." @default.
• W2169916086 created "2016-06-24" @default.
• W2169916086 creator A5021452528 @default.
• W2169916086 creator A5031314668 @default.
• W2169916086 creator A5036623415 @default.
• W2169916086 creator A5043236526 @default.
• W2169916086 creator A5084788916 @default.
• W2169916086 date "2014-01-02" @default.
• W2169916086 modified "2023-10-13" @default.
• W2169916086 title "Efficacy and tolerability of adding coenzyme A 400 U/d capsule to stable statin therapy for the treatment of patients with mixed dyslipidemia: an 8-week, multicenter, double-Blind, randomized, placebo-controlled study" @default.
• W2169916086 cites W1609483177 @default.
• W2169916086 cites W1969054950 @default.
• W2169916086 cites W1974854729 @default.
• W2169916086 cites W1988425004 @default.
• W2169916086 cites W1991695028 @default.
• W2169916086 cites W2001665529 @default.
• W2169916086 cites W2008131041 @default.
• W2169916086 cites W2023516121 @default.
• W2169916086 cites W2027754732 @default.
• W2169916086 cites W2031785623 @default.
• W2169916086 cites W2036747551 @default.
• W2169916086 cites W2037201857 @default.
• W2169916086 cites W2046991199 @default.
• W2169916086 cites W2067746203 @default.
• W2169916086 cites W2068346011 @default.
• W2169916086 cites W2068977057 @default.
• W2169916086 cites W2089440814 @default.
• W2169916086 cites W2092677686 @default.
• W2169916086 cites W2124481954 @default.
• W2169916086 cites W2132010550 @default.
• W2169916086 cites W2132263678 @default.
• W2169916086 cites W2137570167 @default.
• W2169916086 cites W2148195524 @default.
• W2169916086 cites W2149409142 @default.
• W2169916086 cites W2153788691 @default.
• W2169916086 cites W2164324917 @default.
• W2169916086 cites W2170874238 @default.
• W2169916086 cites W2313677450 @default.
• W2169916086 cites W4230870013 @default.
• W2169916086 cites W4238251256 @default.
• W2169916086 doi "https://doi.org/10.1186/1476-511x-13-1" @default.
• W2169916086 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3881496" @default.
• W2169916086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24382338" @default.
• W2169916086 hasPublicationYear "2014" @default.
• W2169916086 type Work @default.
• W2169916086 sameAs 2169916086 @default.
• W2169916086 citedByCount "18" @default.
• W2169916086 countsByYear W21699160862015 @default.
• W2169916086 countsByYear W21699160862016 @default.
• W2169916086 countsByYear W21699160862017 @default.
• W2169916086 countsByYear W21699160862018 @default.
• W2169916086 countsByYear W21699160862020 @default.
• W2169916086 countsByYear W21699160862021 @default.
• W2169916086 countsByYear W21699160862023 @default.
• W2169916086 crossrefType "journal-article" @default.
• W2169916086 hasAuthorship W2169916086A5021452528 @default.
• W2169916086 hasAuthorship W2169916086A5031314668 @default.
• W2169916086 hasAuthorship W2169916086A5036623415 @default.
• W2169916086 hasAuthorship W2169916086A5043236526 @default.
• W2169916086 hasAuthorship W2169916086A5084788916 @default.
• W2169916086 hasBestOaLocation W21699160861 @default.
• W2169916086 hasConcept C126322002 @default.
• W2169916086 hasConcept C134018914 @default.
• W2169916086 hasConcept C142724271 @default.
• W2169916086 hasConcept C168563851 @default.
• W2169916086 hasConcept C197934379 @default.
• W2169916086 hasConcept C204787440 @default.
• W2169916086 hasConcept C27081682 @default.
• W2169916086 hasConcept C2776839432 @default.
• W2169916086 hasConcept C2776919658 @default.
• W2169916086 hasConcept C2778096610 @default.
• W2169916086 hasConcept C2778163477 @default.
• W2169916086 hasConcept C2778375690 @default.
• W2169916086 hasConcept C2778913445 @default.
• W2169916086 hasConcept C2779091943 @default.
• W2169916086 hasConcept C2779134260 @default.
• W2169916086 hasConcept C555293320 @default.
• W2169916086 hasConcept C71924100 @default.
• W2169916086 hasConcept C90924648 @default.
• W2169916086 hasConceptScore W2169916086C126322002 @default.
• W2169916086 hasConceptScore W2169916086C134018914 @default.
• W2169916086 hasConceptScore W2169916086C142724271 @default.
• W2169916086 hasConceptScore W2169916086C168563851 @default.
• W2169916086 hasConceptScore W2169916086C197934379 @default.
• W2169916086 hasConceptScore W2169916086C204787440 @default.
• W2169916086 hasConceptScore W2169916086C27081682 @default.
• W2169916086 hasConceptScore W2169916086C2776839432 @default.
• W2169916086 hasConceptScore W2169916086C2776919658 @default.
• W2169916086 hasConceptScore W2169916086C2778096610 @default.
• W2169916086 hasConceptScore W2169916086C2778163477 @default.
• W2169916086 hasConceptScore W2169916086C2778375690 @default.
• W2169916086 hasConceptScore W2169916086C2778913445 @default.
• W2169916086 hasConceptScore W2169916086C2779091943 @default.
• W2169916086 hasConceptScore W2169916086C2779134260 @default.
• W2169916086 hasConceptScore W2169916086C555293320 @default.
• W2169916086 hasConceptScore W2169916086C71924100 @default.
• W2169916086 hasConceptScore W2169916086C90924648 @default.
• W2169916086 hasIssue "1" @default.
• W2169916086 hasLocation W21699160861 @default.
• W2169916086 hasLocation W21699160862 @default.

• next